"Physiotenses" - antihypertensive drug for the treatment of hypertension.
The analogues of this drug are Moxonitex, Moxonidine, and Zint.
All of them have the same active substance - moxonidine.
Indications for the appointment of "Physiotense" and its analogues
The drug "Physiotenses" is produced inGermany's pharmaceutical company Solvay Pharmaceuticals B.V. Its analogue "Moksonitex" is produced by the German company Salutas Pharma. Its analogue "Zint" is produced by the company "Eli Lilly" (USA). "Moksonidin" is produced by the Russian "Farmaszashchita". These drugs are prescribed for the treatment of hypertension. All drugs have the same active substance - moxonidine.
Moxonidine stimulates sensory receptors,Taking part in the management of the sympathetic nervous system, the activation of these receptors lowers blood pressure. "Physiotenses" or its analogs are prescribed in a dose of 200 mcg per day, the maximum allowable amount of a drug per day is 600 mcg, the maximum possible single dose is 400 mcg. Take "Physiotenses" or replace it with analogs can only after consulting a doctor, self-medication can be dangerous.
If the patient suffers from kidney failure, the daily dose of the drug should be 200 μg.
Side effects, contraindications to the appointment of drugs containing moxonidine
"Physiotenses" and analogues from reviews can causeThe same side effects: temporary dysfunction of the central nervous system (headache, dizziness, drowsiness), excessive lowering of pressure, the tongue and mouth become dry. These drugs can not be taken during pregnancy and lactation. During treatment it is necessary to exclude the use of alcohol, at the beginning of therapy it is not recommended to work with mechanisms, requiring quick reaction and increased attention.
"Physiotenses" and analogues are contraindicated at the age ofUp to 18 years, with increased sensitivity to the active component of the drug, with hereditary intolerance to galactose, a sinus node weakness syndrome with bradycardia (low heart rate). Due to the lack of clinical experience, the use of drugs containing moxonidine in patients with intermittent claudication, Raynaud's disease, depression, epilepsy, parkinsonism, and glaucoma can be dangerous.
"Physiotenses" and analogues with extreme caution should be taken in patients with renal insufficiency and patients on hemodialysis.
If medicines containingMoxonidine, is prescribed together with drugs - beta-adrenoblockers, the effect of moxonidine on blood pressure is enhanced. After the abolition of "Physiotense" and analogues against the backdrop of ongoing treatment with beta-adrenoblocker, there is a risk of severe arterial hypertension. Therefore, in this case, it is recommended first to cancel the beta-blocker, and after a few days the drug with moxonidine. With the simultaneous use of these drugs with drugs that exert a depressing effect on the central nervous system (hypnotics, tranquilizers), the depressing (overwhelming) effect on the central nervous system increases.